Noninvasive ventilation (NIV)
Noninvasive ventilation (NIV) supports the patient’s breathing without the need for intubation or a tracheotomy. In acute settings, NIV delivers effective therapy with less risk of infection and improved survival in patients with respiratory failure.1-2
During acute decompensation of COPD, NIV can support the patient by:
- delivering the right inspiratory and expiratory pressures to support their individual ventilatory demands
- supporting alveolar minute ventilation
- unloading the respiratory muscles
NPPV has the potential of reducing the morbidity and possibly the mortality of hypercapnic respiratory failure.
The benefits of noninvasive ventilation
Where possible, noninvasive ventilation is gaining acceptance around the world as the preferred choice of treatment2 over invasive ventilation and is considered standard practice for acute respiratory failure.3 Suitable for patients in the hospital or the home, noninvasive ventilation:
Can help patients use more of their lung capacity. This in turn decreases the work of breathing,1 which could help patients to complete their daily activities.
Helps alleviate a range of symptoms. Morning headaches, daytime fatigue and shortness of breath are just some of the daytime symptoms that may occur due to low levels of oxygen or accumulated carbon dioxide. By helping to normalize CO2 and O2 levels in the body, noninvasive ventilation therapy helps relieve symptoms over time to improve the patient's quality of life.4
May reduce time in hospital and prevent disease from worsening. Patients treated with noninvasive ventilation therapy tend to spend less time in the hospital.5 By ensuring adequate ventilation, NIV patients may be able to avoid respiratory failure.5